EBITDA

A forgotten corner of oncology is set for a 14.2% CAGR. A new wave of drugs for chemo-induced neuropathy signals a major market realignment.

The XR market is pivoting. Bulky headsets are out, and sleek, everyday glasses are in. Discover the forces driving this change and what it means for tech.

Insurers promise big savings for bundling policies, but in high-risk zones like Florida, this convenience can mask dangerous coverage gaps. Here's the real story.

A new report shows Blue Cross Blue Shield plans have slashed administrative cost growth, a sign of rare efficiency. But what does this mean for your wallet?

A new alliance between Meritus Capital and Republic Business Credit aims to solve a critical cash flow problem for the temporary staffing industry.

With a novel non-hallucinogenic drug, Enveric Biosciences heads to the BIO convention seeking partners. Can its unique science secure its future?

Terreno Realty's latest acquisition in Alexandria isn't just another deal. It's a calculated move in a tight market, revealing a deep strategy for a future where last-mile logistics is king.

GTIA's inaugural Innovate Awards move past AI hype, showcasing six firms whose practical solutions are already transforming the IT channel's efficiency and impact.

RLTYco launches RLTYconsulting, led by industry veterans, to offer brokerages a unique blend of strategic growth advice and back-end financial automation.

A Quebec startup's strategic hires reveal a critical shift in the quantum race, where translating science into value is now as vital as the breakthroughs themselves.

In a tough fundraising climate, Clearlake Capital's massive $14.8B close isn't just a win; it's a strategic bet on the AI-driven future of industry.

With the hire of Patrick Duffy, Dropzone AI signals a major push in its mission to solve cybersecurity's twin crises with a new breed of AI agents.

A Google spin-off is auctioning AI-developed scent molecules, challenging a secretive, century-old industry. This is how technology is digitizing smell.

After a fatal crash, a private jet operator is publicly demanding regulators and GE fix a critical safety gap where known corrosion goes unreported.

As London Climate Action Week begins, a key summit gathers leaders from F1 to finance to move past pledges and tackle ESG, supply chains, and the urgent water crisis.

Eclipse Automation's new RealitySync platform lets manufacturers walk through factories before they exist. Is this just a tech demo or the future of de-risking industrial investments?

BioAge Labs starts a Phase 2 trial for BGE-102, an oral drug targeting inflammation to reduce heart risk, a strategy that could redefine cardiovascular care.

Intrepid Fiber's expansion into the Inland Empire pits its open-access model against incumbents and new rivals in a high-stakes battle for the future of broadband.

Private equity firm Sagewind Capital's latest hire isn't just another suit. It's a strategic move revealing a much deeper trend in high-stakes GovTech.

A new Supreme Court ruling just upended risk for freight brokers. RoxStart AI's new platform offers a timely, tech-driven defense for the industry's backbone.